160Authorisation conditions for supplying medicines during

160 Authorisation conditions for supplying medicines during consultations—Act, s 44 (1) (b) and (2) (b) A prescriber’s authorisation under section 110 or section 490 to supply a medicine during a consultation is subject to the following conditions: (a) the medicine is supplied in accordance with the Act, section 7 (Appropriate prescription and supply of medicines); (b) if the medicine is a controlled medicine for human use— (i) the prescriber complies with the additional requirements under section 163 (Additional requirements for supplying controlled medicines for human use during consultations) in relation to the supply; and (ii) if the medicine is dronabinol—the prescriber has an authorisation under the Therapeutic Goods Act 1989 (Cwlth), section 19 to supply the medicine; and Note Dronabinol cannot be prescribed for veterinary use because it is a prohibited substance (see medicines and poisons standard, sch 9, entry for tetrahydrocannabinols). (iii) the prescriber complies with section 164 (Information for CHO about monitored medicines supplied during consultations—Act, s 31 (2) (b) and (4), def required information); (c) if the medicine is an appendix D medicine— (i) the prescriber has an appendix D medicines approval to prescribe the medicine; and

Supplying medicines during consultations Division 4.2.6 approval (including any conditions in the schedule, part 3.2, column 4 in relation to the medicine); (d) the medicine is labelled in accordance with section 161; (e) the supply is recorded in accordance with section 162; (f) the record is kept at the prescriber’s business premises or, if the chief health officer approves in writing another place, the place day the medicine is supplied.